Australian researchers develop new risk scoring system to predict childhood leukemia relapse
Can't see this email? View it online
   
  December 6, 2017  
  Hematology  
  The latest hematology news from News Medical  
 Australian researchers develop new risk scoring system to predict childhood leukemia relapseAustralian researchers develop new risk scoring system to predict childhood leukemia relapse
 
Australian researchers have developed a new risk scoring system for children with leukemia based on missing DNA fragments or 'microdeletions'.
 
 
 AMSBIO offers new cryopreservation medium for banking of hematopoietic stem cellsAMSBIO offers new cryopreservation medium for banking of hematopoietic stem cells
 
HSC-BANKER from AMSBIO is a new optimised GMP grade cryopreservation medium for the banking of hematopoietic stem cells isolated from umbilical cord blood, peripheral blood and bone marrow.
 
   UC San Diego researchers receive nearly $8 million grant for new stem cell-based AML treatmentsUC San Diego researchers receive nearly $8 million grant for new stem cell-based AML treatments
 
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.
 
   Tests for Ureteric Calculi: Radiograph, CT and UltrasoundTests for Ureteric Calculi: Radiograph, CT and Ultrasound
 
Stones found within the slender muscular tubes that carry urine from the kidneys to the bladder are referred to as ureteric calculi. These stones may be caused by factors such as a faulty diet, chronic urinary tract infections (UTIs) with or without abnormal urinary tract anatomy, metabolic dysfunction and hormonal imbalances.
 
   Scientists create low-cost, rapid test to detect iron and vitamin A deficienciesScientists create low-cost, rapid test to detect iron and vitamin A deficiencies
 
Cornell University engineers and nutritionists have created a swift solution for a challenging global health problem: a low-cost, rapid test to detect iron and vitamin A deficiencies at the point of care.
 
 FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers
 
FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancersThe U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).
 
 
 Study elucidates how lymphocytes regulate immune response after heart attacks
 
Study elucidates how lymphocytes regulate immune response after heart attacksThe damage caused by a heart attack triggers an inflammatory reaction which degrades the affected tissue. This response is orchestrated by immune cells that reside in the nearby pericardial adipose tissue, as a study by a team of Ludwig-Maximilians-Universitaet) in Munich shows.
 
 
 New targeted treatment could benefit patients with certain pancreatic tumors
 
New targeted treatment could benefit patients with certain pancreatic tumorsResearchers at the University of Cincinnati College of Medicine have shown that a new targeted treatment could benefit patients with certain pancreatic tumors by preventing spread of the cancer and protecting their heart from damage--a direct result of the tumor.
 
 
 OICR announces innovative initiative to drive development of new cancer therapies
 
OICR announces innovative initiative to drive development of new cancer therapiesThe Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.
 
 
 High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma
 
High ADAR1 enzyme levels correlate with reduced survival rates in multiple myelomaMultiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1.
 
 
 NIH grant supports research on cellular mechanisms governing longevity
 
NIH grant supports research on cellular mechanisms governing longevityThe MDI Biological Laboratory has announced that Aric Rogers, Ph.D., has received a grant of $455,000 over two years from the National Institute on Aging, one of the institutes of the National Institutes of Health, for research on the cellular mechanisms governing longevity.
 
 
 MUSC researchers develop ex vivo model of pressure-induced cellular injury in the brain
 
MUSC researchers develop ex vivo model of pressure-induced cellular injury in the brainHundreds of thousands of patients from newborns to the elderly are forced to grapple with the devastation of brain injury each year, and unlike many diseases where certain demographics are protected, brain injury can happen to anyone, anytime and anywhere.